STAT+: Pharma is a ‘mixed bag’ when providing drug access to low- and middle-income countries, analysis finds
Many large pharmaceutical companies are taking steps to improve access to their medicines in low- and middle-income countries, but progress has been mixed and more action is needed to ensure wide availability, a new analysis found. Notably, more…
ImpactNotable
Published3 h ago (Tue, 10 Nov 2026 13:00:00 GMT)
AuthorEd Silverman
MoreLess
Impact score33/100
RatingRule-based estimate: no strong signals; trust 8/10.
RegionsGlobal
Retrievedvia rss
ClassifiedTue, 10 Nov 2026 14:02:44 GMT by heuristic